Share-based payments (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Statement [Line Items] |
|
| Summary of number and weighted average exercise prices (WAEP) of, and movements in, share options |
The following table shows the number of stock options granted, cancelled and the weighted average exercise price (“WAEP”) for the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended December 31,
2025 |
|
|
Year ended December 31,
2024 |
|
|
Year ended December 31,
2023 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
3,357,263 |
|
|
|
52.40 |
|
|
|
394,201 |
|
|
|
29.71 |
|
|
|
513,379 |
|
|
|
17.83 |
|
Cancelled during the year (1) |
|
|
— |
|
|
|
— |
|
|
|
(20,029 |
) |
|
|
6.21 |
|
|
|
(1,188,362 |
) |
|
|
3.68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Related to stock options annulled or cancelled for the year, which has no relation with the options exercised. |
|
| Summary of valuation assumptions of stock option plan |
The following table shows the inputs used for the plan for the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
0.0% |
|
|
|
0.0% |
|
|
|
0.0% |
|
| |
|
|
50.1% |
|
|
|
32.1% |
|
|
|
31.4% |
|
Risk–free interest rate (%) |
|
|
4.3% |
|
|
|
4.1% |
|
|
|
3.9% |
|
Expected life of share options (years) |
|
|
7 |
|
|
|
10 |
|
|
|
10 |
|
| |
|
|
52.40 |
|
|
|
29.71 |
|
|
|
17.83 |
|
| |
|
|
Black & Scholes |
|
|
|
Black & Scholes |
|
|
|
Black & Scholes |
|
|
| Summary of number and weighted average exercise prices (WAEP) of, and movements in, restricted stock |
The following table shows the number of restricted stock granted, cancelled and WAEP for the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended
December 31, 2025 |
|
|
Year ended
December 31, 2024 |
|
|
Year ended
December 31, 2023 |
|
| |
|
Number of
Series A shares |
|
|
|
|
|
Number of
Series A shares |
|
|
|
|
|
Number of
Series A shares |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
186,585 |
|
|
|
49.58 |
|
|
|
267,033 |
|
|
|
32.17 |
|
|
|
519,025 |
|
|
|
17.83 |
|
Cancelled during the year (1) |
|
|
(297,558 |
) |
|
|
10.10 |
|
|
|
(704,741 |
) |
|
|
5.96 |
|
|
|
(555,451 |
) |
|
|
2.13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Related to restricted stock annulled or cancelled for the year, which has no relation with the restricted stock vested. |
|
| Performance Restricted Stock [Member] |
|
| Statement [Line Items] |
|
| Summary of number and weighted average exercise prices (WAEP) of, and movements in, restricted stock |
The following table shows the number of performance restricted stock granted and WAEP for the year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Year ended
December 31, 2025 |
|
|
Year ended
December 31, 2024 |
|
|
|
|
| |
|
Number of
Series A shares |
|
|
|
|
|
Number of
Series A shares |
|
|
|
|
|
Number of
Series A shares |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
48,324 |
|
|
|
51.07 |
|
|
|
422,941 |
|
|
|
30.00 |
|
|
|
1,417,589 |
|
|
|
17.83 |
|
Cancelled during the year (1) |
|
|
(1,520,887 |
) |
|
|
7.05 |
|
|
|
(21,277 |
) |
|
|
7.05 |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Related to performance restricted stock annulled or cancelled for the year, which has no relation with the performance restricted stock vested. |
|